<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>heparin</title><link>http://www.unboundmedicine.com/medline/ebm/research/heparin</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>A Novel HPLC Method for Quantification of 10 Antiepileptic Drugs or Metabolites in Serum/Plasma Using a Monolithic Column.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19927045/full_citation/A_Novel_HPLC_Method_for_Quantification_of_10_Antiepileptic_Drugs_or_Metabolites_in_Serum/Plasma_Using_a_Monolithic_Column_</link><description>Heideloff C, Bunch DR, Wang S <br/><span class="title">A Novel HPLC Method for Quantification of 10 Antiepileptic Drugs or Metabolites in Serum/Plasma Using a Monolithic Column. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19927045/abstract/A_Novel_HPLC_Method_for_Quantification_of_10_Antiepileptic_Drugs_or_Metabolites_in_Serum/Plasma_Using_a_Monolithic_Column_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19927045/full_citation/A_Novel_HPLC_Method_for_Quantification_of_10_Antiepileptic_Drugs_or_Metabolites_in_Serum/Plasma_Using_a_Monolithic_Column_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19927045/A_Novel_HPLC_Method_for_Quantification_of_10_Antiepileptic_Drugs_or_Metabolites_in_Serum/Plasma_Using_a_Monolithic_Column_">Find Related Articles</a> </description></item><item><title>Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926322/full_citation/Evaluation_of_heparin_cofactor_II_thrombin_complex_as_a_biomarker_on_blood_spots_from_mucopolysaccharidosis_I_IIIA_and_IIIB_mice_</link><description>Langford-Smith K, Arasaradnam M, Wraith JE, et al. <br/><span class="title">Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice. [JOURNAL ARTICLE]</span><br/><span class="source" title="Molecular genetics and metabolism">Mol Genet Metab 2009 Oct 23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926322/abstract/Evaluation_of_heparin_cofactor_II_thrombin_complex_as_a_biomarker_on_blood_spots_from_mucopolysaccharidosis_I_IIIA_and_IIIB_mice_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19926322/full_citation/Evaluation_of_heparin_cofactor_II_thrombin_complex_as_a_biomarker_on_blood_spots_from_mucopolysaccharidosis_I_IIIA_and_IIIB_mice_">Full Citation</a></description></item><item><title>A review of 122 published outcomes of danaparoid anticoagulation for intermittent haemodialysis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926118/full_citation/A_review_of_122_published_outcomes_of_danaparoid_anticoagulation_for_intermittent_haemodialysis_</link><description>Magnani HN <br/><span class="title">A review of 122 published outcomes of danaparoid anticoagulation for intermittent haemodialysis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Thrombosis research">Thromb Res 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926118/abstract/A_review_of_122_published_outcomes_of_danaparoid_anticoagulation_for_intermittent_haemodialysis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19926118/full_citation/A_review_of_122_published_outcomes_of_danaparoid_anticoagulation_for_intermittent_haemodialysis_">Full Citation</a></description></item><item><title>Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926048/full_citation/Enoxaparin_Versus_Unfractionated_Heparin_in_Elective_Percutaneous_Coronary_Intervention_1_Year_Results_From_the_STEEPLE__SafeTy_and_Efficacy_of_Enoxaparin_in_Percutaneous_coronary_intervention_patients_an_internationaL_randomized_Evaluation__Trial_</link><description>Montalescot G, Gallo R, White HD, et al. <br/><span class="title">Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="JACC. Cardiovascular interventions">JACC Cardiovasc Interv 2009 Nov; 2(11):1083-1091.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926048/abstract/Enoxaparin_Versus_Unfractionated_Heparin_in_Elective_Percutaneous_Coronary_Intervention_1_Year_Results_From_the_STEEPLE__SafeTy_and_Efficacy_of_Enoxaparin_in_Percutaneous_coronary_intervention_patients_an_internationaL_randomized_Evaluation__Trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19926048/full_citation/Enoxaparin_Versus_Unfractionated_Heparin_in_Elective_Percutaneous_Coronary_Intervention_1_Year_Results_From_the_STEEPLE__SafeTy_and_Efficacy_of_Enoxaparin_in_Percutaneous_coronary_intervention_patients_an_internationaL_randomized_Evaluation__Trial_">Full Citation</a></description></item><item><title>Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925675/full_citation/Topical_recombinant_thrombin_at_a_concentration_of_1000_IU/mL_reliably_shortens_in_vivo_TTH_and_delivers_durable_hemostasis_in_the_presence_of_heparin_anticoagulation_and_clopidogrel_platelet_inhibition_in_a_rabbit_model_of_vascular_bleeding_</link><description>Hughes SD, Bishop PD, Garcia R, et al. <br/><span class="title">Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of surgical innovation and research">Ann Surg Innov Res 2009 Nov 19; 3(1):14.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925675/abstract/Topical_recombinant_thrombin_at_a_concentration_of_1000_IU/mL_reliably_shortens_in_vivo_TTH_and_delivers_durable_hemostasis_in_the_presence_of_heparin_anticoagulation_and_clopidogrel_platelet_inhibition_in_a_rabbit_model_of_vascular_bleeding_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925675/full_citation/Topical_recombinant_thrombin_at_a_concentration_of_1000_IU/mL_reliably_shortens_in_vivo_TTH_and_delivers_durable_hemostasis_in_the_presence_of_heparin_anticoagulation_and_clopidogrel_platelet_inhibition_in_a_rabbit_model_of_vascular_bleeding_">Full Citation</a></description></item><item><title>Hepatocyte Growth Factor/Activin A/Follistatin System Activation during Hemodialysis with Different Low Molecular Weight Heparins.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925286/full_citation/Hepatocyte_Growth_Factor/Activin_A/Follistatin_System_Activation_during_Hemodialysis_with_Different_Low_Molecular_Weight_Heparins_</link><description>Rydzewska-Rosołowska A, Borawski J, Myśliwiec M <br/><span class="title">Hepatocyte Growth Factor/Activin A/Follistatin System Activation during Hemodialysis with Different Low Molecular Weight Heparins. [JOURNAL ARTICLE]</span><br/><span class="source" title="Renal failure">Ren Fail 2009 Jan; 31(9):791-797.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925286/abstract/Hepatocyte_Growth_Factor/Activin_A/Follistatin_System_Activation_during_Hemodialysis_with_Different_Low_Molecular_Weight_Heparins_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925286/full_citation/Hepatocyte_Growth_Factor/Activin_A/Follistatin_System_Activation_during_Hemodialysis_with_Different_Low_Molecular_Weight_Heparins_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19925286/Hepatocyte_Growth_Factor/Activin_A/Follistatin_System_Activation_during_Hemodialysis_with_Different_Low_Molecular_Weight_Heparins_">Find Related Articles</a> </description></item><item><title>Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923984/full_citation/Unusual_onset_of_venous_thromboembolism_and_heparin_induced_thrombocytopenia_in_a_patient_with_essential_thrombocythemia_</link><description>Lapecorella M, Lucchesi A, Di Ianni M, et al. <br/><span class="title">Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia. [JOURNAL ARTICLE]</span><br/><span class="source" title="Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis">Blood Coagul Fibrinolysis 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923984/abstract/Unusual_onset_of_venous_thromboembolism_and_heparin_induced_thrombocytopenia_in_a_patient_with_essential_thrombocythemia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923984/full_citation/Unusual_onset_of_venous_thromboembolism_and_heparin_induced_thrombocytopenia_in_a_patient_with_essential_thrombocythemia_">Full Citation</a></description></item><item><title>[Preparation and property of platinum microcoil modified by a copolymer-VEGF conjugate.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923058/full_citation/[Preparation_and_property_of_platinum_microcoil_modified_by_a_copolymer_VEGF_conjugate_]</link><description>Wang QJ, Sun XL, Ji B, et al. <br/><span class="title">[Preparation and property of platinum microcoil modified by a copolymer-VEGF conjugate.] [JOURNAL ARTICLE]</span><br/><span class="source" title="Nan fang yi ke da xue xue bao = Journal of Southern Medical University">Nan Fang Yi Ke Da Xue Xue Bao 2009 Nov 20; 29(11):2171-2174.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923058/abstract/[Preparation_and_property_of_platinum_microcoil_modified_by_a_copolymer_VEGF_conjugate_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923058/full_citation/[Preparation_and_property_of_platinum_microcoil_modified_by_a_copolymer_VEGF_conjugate_]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19923058/[Preparation_and_property_of_platinum_microcoil_modified_by_a_copolymer_VEGF_conjugate_]">Find Related Articles</a> </description></item><item><title>When 'never-events' occur despite adherence to clinical guidelines: The case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922988/full_citation/When_'never_events'_occur_despite_adherence_to_clinical_guidelines:_The_case_of_venous_thromboembolism_in_clear_cell_cancer_of_the_ovary_compared_with_other_epithelial_histologic_subtypes_</link><description>Duska LR, Garrett L, Henretta M, et al. <br/><span class="title">When 'never-events' occur despite adherence to clinical guidelines: The case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes. [JOURNAL ARTICLE]</span><br/><span class="source" title="Gynecologic oncology">Gynecol Oncol 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922988/abstract/When_'never_events'_occur_despite_adherence_to_clinical_guidelines:_The_case_of_venous_thromboembolism_in_clear_cell_cancer_of_the_ovary_compared_with_other_epithelial_histologic_subtypes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922988/full_citation/When_'never_events'_occur_despite_adherence_to_clinical_guidelines:_The_case_of_venous_thromboembolism_in_clear_cell_cancer_of_the_ovary_compared_with_other_epithelial_histologic_subtypes_">Full Citation</a></description></item><item><title>Polymer Dynamics in Layer-by-Layer Assemblies of Chitosan and Heparin.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19921830/full_citation/Polymer_Dynamics_in_Layer_by_Layer_Assemblies_of_Chitosan_and_Heparin_</link><description>Lundin M, Blomberg E, Tilton RD <br/><span class="title">Polymer Dynamics in Layer-by-Layer Assemblies of Chitosan and Heparin. [JOURNAL ARTICLE]</span><br/><span class="source" title="Langmuir : the ACS journal of surfaces and colloids">Langmuir 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19921830/abstract/Polymer_Dynamics_in_Layer_by_Layer_Assemblies_of_Chitosan_and_Heparin_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19921830/full_citation/Polymer_Dynamics_in_Layer_by_Layer_Assemblies_of_Chitosan_and_Heparin_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19921830/Polymer_Dynamics_in_Layer_by_Layer_Assemblies_of_Chitosan_and_Heparin_">Find Related Articles</a> </description></item></channel></rss>